|
J Biol Chem, Vol. 273, Issue 29, 18633-18639, July 17, 1998
Molecular Cloning and Characterization of the Mouse
tag7 Gene Encoding a Novel Cytokine*
Sergei L.
Kiselev §¶,
Olga S.
Kustikova § ,
Elena V.
Korobko §,
Egor B.
Prokhortchouk ,
Andrei A.
Kabishev ,
Evgenii M.
Lukanidin , and
Georgii P.
Georgiev
From the Institute of Gene Biology,
34/5 Vavilova St., Moscow 117334, Russia and the Danish Cancer
Society, Strandboulevarden 49, 7.1, DK-2100 Copenhagen, Denmark
 |
ABSTRACT |
Cloning of the mouse tag7 gene
encoding a novel cytokine is described. The Tag7 protein consists of
182 amino acids. Genomic organization of the tag7 gene and
its promoter region remind those of the genes of the tumor necrosis
factor locus, although the tag7 gene is not linked to this
locus. The gene is located on chromosome 7 at the area that corresponds
to band 7A3, which has genetic linkage with lupus-like disease in mouse
models. tag7 transcription is essential for lymphoid
organs. It is also detected in certain areas of lungs, brain, and
intestine and in some tumors. Tag7 protein is detectable in both
cell-associated and soluble forms. The soluble form of Tag7 triggers
apoptosis in mouse L929 cells in vitro and does not involve
NF- B activation. The relationship between Tag7 and tumor necrosis
factor family of ligands is discussed.
 |
INTRODUCTION |
The term "cytokine" has come to be used for a diverse group of
growth factors, inflammatory mediators, and hematopoietic regulators that are distinct from more classical hormones secreted by the glands
of the endocrine system. Cytokines are proteins that act as a soluble
cell to cell messengers, distinguished by their high interactivity, and
can act in both autocrine and paracrine manners.
Neoplastic cells themselves characteristically produce cytokines
spontaneously, and even in the same lineage, they can have distinct
cytokine expression and/or secretion profiles (1-4). Cytokines
secreted by tumors could be used either as autocrine factors, to
recruit and suppress reactive leukocytes, or to modulate the activity
of endothelial and stromal cells. The ability to release cytokine in an
autocrine manner could be a key factor in the promotion of neoplastic
transformation and in permitting tumor growth in vivo (5).
In their turn, cytokines produced by the host in response to a tumor
modify the scenario created by tumor growth (6). The analysis of
expression of cytokine genes by tumors indicated that cells
constitutively produced both autostimulatory and inhibitory cytokines.
Expression of several cytokines, including interleukin-1
(IL-1 ),1 IL-6, IL-8,
IL-10, tumor necrosis factor- , lymphotoxin- , and granulocyte-macrophage colony-stimulating factor by some tumors has
been described. Tumor necrosis factor (TNF) and lymphotoxin- (LT- , also known as TNF- ) are related cytokines involved in many
regulatory activities (7, 8), but their roles in the immune system
although suggesting very critical functions (9) are still enigmas. TNF
and LT- are released by a number of tumor cells originating in mouse
fibrosarcoma, epithelial human cell lines, and T-cell leukemia
(10-12).
In this study, we used a pair of related mouse transplanted tumors with
the opposite metastatic properties to identify genes overexpressed in
one of them. As a result, the tag7 gene was cloned. It was
expressed in tumor with high metastatic potential, although no
correlation with metastatic potential was detected after study of many
different tumors. The tag7 gene is preferentially
transcribed in normal lymphoid and hematopoietic cells. Tag7 is a
secreted protein possessing a significant cytotoxicity realized through apoptosis.
 |
MATERIALS AND METHODS |
Cells and Cell Cultures--
VMR-0, VMR-L, CSML-0, and CSML-100
cell lines were established from their respective mammary
adenocarcinoma transplanted tumors described in Ref. 13. Cell lines
saved their ability to produce tumors in syngenetic mice with low
(VMR-0 and CSML-0) and high (VMR-L and CSML-100) metastatic potential
when injected subcutaneously. Mouse splenocytes, thymocytes, monocytes,
and peritoneal macrophages were isolated as described previously (14).
Cells were cultured in RPMI 1640 medium containing 5% FBS 100 units/ml
penicillin, 100 units/ml streptomycin, 10 mM HEPES. Cells
were activated with LPS (5 µg/ml) in serum-free medium for different
time. VMR-0 cells were transfected with the pM5Gneo tag7
construct or mock-transfected using Lipofectin reagent (Life
Technologies, Inc.) according to the manufacturer's recommendations,
and clones were selected on G418 resistance and maintained.
Cloning of the tag7 Gene--
A fragment of the tag7
cDNA was isolated by differential display technique essentially as
described by Liang and Pardee (15). T12AC oligonucleotide
was used as the anchoring primer, and AATCGGGCTG was used as the
arbitrary primer. A fragment of 390 bp was used as a probe for Northern
blot hybridization and cDNA library screening (16). cDNA
library was prepared on poly(A)+ RNA isolated from VMR-L
tumors using ZAP-cDNA Gigapack Cloning kit (Stratagene) according
to the manufacturer's recommendation. Positive clones were purified,
and the inserts were excised as pBluescript clones using helper phage
as described by the manufacturer. Few clones were sequenced using
Sequenase Version 2.0 sequencing kit (Amersham Pharmacia Biotech) and
synthetic oligonucleotide primers (Applied Biosystems 391 DNA
synthesizer). Genomic library was constructed in the FIX II vector
(Stratagene) and screened according to a standard procedure (16). The
inserts were subcloned in pGEM7Z vector and partially sequenced as
described above.
RNA Hybridization--
Total RNA from tumors and cell lines was
isolated by guanidine thiocyanate procedure, resolved on a 1.2%
agarose-formaldehyde gel, and blotted onto Hybond-N as recommended
by the manufacturer (Amersham Pharmacia Biotech). The
EcoRI/XhoI fragment from the longest cDNA
clone was labeled by random priming and used as a probe. To equalize an
amount of RNA loaded on each lane, hybridization with
glyceraldehyde-3-phosphate dehydrogenase DNA probe was performed. In situ hybridization was performed as described previously
(17).
DNAs--
Oligonucleotides were synthesized corresponding to the
5' and 3' ends of the coding regions of the mouse tag7 gene,
with BamHI and HindIII restriction sites appended
to the ends of oligonucleotides. The coding region of the gene was
amplified by standard polymerase chain reaction techniques, cut with
BamHI and HindIII, and inserted in frame in the
BamHI and HindIII sites of the pQE30 expression vector (Qiagen). For eucaryotic expression, full-sized tag7
cDNA was subcloned in NheI-XhoI sites of
pBK-CMV (Stratagene) and EcoRI-BamHI sites of
pM5Gneo vectors.
Chromosomal Mapping of the tag7 Gene--
Fluorescence in
situ hybridization on metaphase mouse chromosomes was performed by
Genome Systems, Inc.
Immunological Methods--
Escherichia coli
recombinant Tag7 protein was expressed in M15[pREP4] (Qiagen) and
purified on Ni-NTA agarose (Qiagen) as recommended by the
manufacturer. Rabbit antibodies raised against recombinant Tag7 were
affinity-purified on a Sepharose (Amersham Pharmacia Biotech) column
with the immobilized recombinant Tag7, as recommended by the
manufacturer. SDS-polyacrylamide gel electrophoresis, immunoprecipitation, and immunoblotting were performed according to
standard procedures (16). The approximate amount of secreted Tag7 by
VMRSX8 clone was determined by immunoblotting.
Analysis of Tag7 Multimeric Structure--
Mouse splenocytes
(1.5 × 108 cells) were treated with LPS for 18 h
on two 100-mm dishes as described above. After that, Complete Mini
EDTA-free protease inhibitor mix (Boehringer Mannheim) and EDTA to
final concentration 1 mM were added to conditioned medium. Conditioned medium was concentrated and fractionated on Superdex 75 HR10/30 column (Amersham Pharmacia Biotech) in 20 mM
Tris-HCl, pH 7.5, 100 mM NaCl according to the
manufacturer's recommendation. For column calibration, bovine milk
-lactalbumin (14.2 kDa), bovine erythrocyte carbonic anhydrase (29 kDa), and chicken egg ovalbumin (45 kDa) (Sigma) were used. Proteins
from collected fractions were precipitated with trichloroacetic acid,
resolved by 15% SDS-polyacrylamide gel electrophoresis, and
transferred to membrane. The membrane was then probed with anti-Tag7
polyclonal antiserum.
Tag7 Cytotoxicity Assay and Neutralization of Cytotoxic
Activity--
As a source of the native form of the Tag7 protein, the
medium conditioned by the VMR-0 pM5Gneo tag7
(VMRSX8)-transfected cells was used. L929 cells were cultured in
96-well plates at a density of 3 × 104 cells/well.
After overnight incubation, cells were treated with actinomycin D (1 µg/ml) for 2 h at 37 °C in serum-free medium. After that, 100 µl/well of the VMRSX8-conditioned medium or VMR-0-conditioned medium
were added. As indicated, recombinant human TNF (rhTNF) (Sigma) was
added at a concentration of 10 ng/ml in a volume of 100 µl/well. To
determine cell death, CytoTox 96 Assay kit (Promega) was used or cells
were stained with trypan blue and the coded samples were counted under
the microscope in a blind fashion, with a minimum of 100 cells scored
for each group.
Neutralization of the cytotoxic effect of the Tag7 protein or rhTNF was
performed using affinity-purified polyclonal rabbit anti-Tag7 and
polyclonal anti-hTNF (Sigma) antibodies. Polyclonal antibodies were
added to the VMRSX8-conditioned medium at a final concentration of 2 µg/ml, and the cytotoxic effect was determined as described above;
rabbit IgG in the same concentration was used as a control.
DNA Fragmentation Analysis--
DNA fragmentation analysis was
performed as described (18), with modifications. In brief, 2 × 106 L929 cells were preincubated with actinomycin D (1 µg/ml) for 2 h at 37 °C in serum-free medium and subsequently
incubated with the VMRSX8-conditioned medium or rhTNF for 5 h.
Cells were harvested and lysed in 20 mM Tris-HCl, pH 8.0, 0.8% Triton X-100, 10 mM EDTA, pH 8.0. After
centrifugation, DNA from the supernatant was precipitated at -20 °C
by isopropanol in the presence of NaCl. DNA was resuspended in TE
buffer (10 mM Tris-Cl, pH 7.4, 1 mM EDTA, pH
8.0) and treated with RNase A, and fragments were resolved in 1.8%
agarose gel in TBE buffer (90 mM Tris-borate, 90 mM boric acid, 2 mM EDTA).
NF- B Activation Assay--
Nuclear extracts were obtained as
described in Ref. 19, and EMSA was performed according to Refs. 16 and
20. NF- B consensus oligonucleotide (Promega) was used for gel shift
assay.
 |
RESULTS |
Isolation and Structure of the Murine tag7 Gene--
A system of
two related mouse transplanted tumors with opposite metastatic
potentials was used to isolate mRNA molecules specifically expressed in one of them. A fragment of complementary DNA was isolated
by the differential display technique from the highly metastatic mouse
mammary adenocarcinoma VMR-L as overexpressed mRNA in comparison
with the nonmetastatic tumor VMR-0. The fragment gave rise to the
0.7-kb mRNA transcript specific for highly metastatic VMR-L tumor.
This gene was designated tag7.
A cDNA library was constructed with mRNA from VMR-L tumor in a
ZAP II vector, and the fragment was used as a probe to isolate complementary DNA. Most of the cDNA clones were sequenced. The tag7 cDNA is predicted to encode a protein 182 amino
acids long with a molecular mass of 20.2 kDa (Fig.
1). Hydropathy computer analysis
suggested the presence of a signal sequence (amino acids 1-21) for
translation into endoplasmic reticulum followed by extracellular region
(amino acids 22-181). The existence of signal peptide indicates that
the protein product may be secreted. Protein data base searches (FASTA
program from IntelliGenetics and BLAST from the National Center for
Biotechnology Information) revealed no significant similarity between
the Tag7 polypeptide and known gene products.

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 1.
Nucleotide and predicted amino acid sequences
corresponding to tag7 cDNA and genomic DNA.
Nontranscribed sequences are indicated by lowercase type.
Amino acids are numbered in boldface starting with the first
predicted methionine. Cysteines are shown in boldface. The
termination codon is denoted by an asterisk. The nucleotides
indicating the start of the cDNA are underlined. The
nonconsensus TATA box is shown by a dashed line. Potential
binding sites for transcription factors are indicated. The potential
signal sequence and the transmembrane domain are underlined,
and the polyadenylation signal is boxed.
|
|
To obtain a genomic copy of the tag7 gene, a mouse genomic
library was constructed in FIXII vector and screened, and the genomic structure of tag7 was established. The murine
tag7 gene spans 8 kb, consists of three exons, and contains
a nonconsensus TATA box (Fig. 1). The mRNA start site was mapped
using primer extension (data not shown), revealing two initiation
starts separated by four nucleotides 22 bp downstream of the TATA box,
probably due to the nonconsensus structure of the latter.
Computer analysis of approximately 200 bp of the upstream sequence
(Signal Scan) revealed a number of potential binding sites for some
known transcription factors, such as Ets-1, NF- B, Sp-1, and MyoD
(Fig. 1). The order of binding sites and the distance from the mRNA
start site are very close to the control region of mouse LT- gene
(21). Furthermore, the 5'-untranslated end of the mRNA was short,
which is also typical for lymphotoxin genes.
Chromosomal Mapping of tag7--
To determine chromosomal
localization of tag7 in mouse genome, metaphase chromosomes
were analyzed by fluorescence in situ hybridization. A total
of 80 metaphase cells were analyzed; 62 exhibited specific labeling.
This experiment resulted in the specific labeling of the centromeric
region of chromosome 7 (data not shown). Measurements of 10 specifically hybridized chromosomes 7 demonstrated that signal is
located at a position that is 9% of the distance from the centromere,
an area that corresponds to band 7A3.
Transcription of tag7 Is Specific for Lymphoid and Some Other
Cells--
Northern hybridization was used to estimate the correlation
between tag7 mRNA expression and metastatic properties
of tumors. However, no correlation was observed upon hybridization with
total RNA of CSML-0 and CSML-100 tumors (Fig.
2). Moreover, the expression of the
tag7 gene appeared to be specific in this pair for the tumor
with a low metastatic capacity, CSML-0. There was also no correlation
between the metastatic potential and tag7 mRNA
expression in other tested murine tumor cell lines (data not shown).
The tag7 mRNA level dramatically altered after the
establishment of the tumors as a cell culture (Fig. 2). In an
established cell line from VMR-L tumors, the level of tag7
transcription dropped down, whereas in the CSML-0 cell line, obtained
from corresponding tumors, it appeared to be up-regulated. Thus,
tag7 in transplanted tumor is regulated by the host
factors.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 2.
tag7 transcription in different tumors
and its alteration after establishment of tumors as cell lines.
Northern hybridization of total RNA isolated from different sources
with labeled Tag7 cDNA. All lanes used 20 µg of total RNA.
tag7 transcript is indicated by the arrow.
Below, hybridization of the same membrane with
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is
shown.
|
|
To determine the tissue-specific pattern of tag7
transcription, Northern blot analyses and in situ
hybridization were performed. Northern hybridization of several adult
mouse tissues (Fig. 3A) revealed the highest level of tag7 transcription in the
lungs and spleen, a detectable level in brain and thymus, and no
mRNA content or just a very low level in the other tissues tested. However, in situ hybridization performed on sections of
selected organs allowed us to detect a high level of tag7
transcripts in certain areas of brain and intestine (Fig. 3,
B-E). Only single, randomly distributed cells were labeled
in the thymus. In the lungs, the label was concentrated in the
intraalveolar space, where, presumably, alveolar macrophages are
located (data not shown). Very characteristic pictures were observed in
the brain, where the distribution of tag7-expressing cells
was extremely nonrandom. In the cerebellum, Purkinje cells were
specifically labeled. Similarly, only certain layers of neurons were
positive in hippocampus (Fig. 3, B and C).
Finally, strong expression of the tag7 gene could be
detected among the cells filling the space within the intestinal villus
(Fig. 3D).

View larger version (90K):
[in this window]
[in a new window]
|
Fig. 3.
Tissue distribution of tag7
transcripts. A, Northern blot analysis of total
RNA isolated from indicated tissues of a healthy mouse. tag7
transcript is indicated by the arrow. All lanes used 20 µg
of total RNA. Below, hybridization of the same membrane with
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is shown.
B-E, in situ hybridization of adult mouse tissue
sections with 35S-labeled tag7 cRNA probes.
B, part of the hippocampus regions and dentate gyrus;
C, part of the cerebellum (Purkinje cells (PC)
are intensely labeled); D, intestinal section; E,
the intestinal section was digested with RNase before
hybridization.
|
|
Considering a similarity in distribution of cis-regulatory elements of
the tag7 and LT- genes, we analyzed tag7
expression in some mouse lymphoid cells. Northern blot analysis was
performed with total RNA isolated from mouse circulating monocytes,
thymocytes, splenocytes, and resident peritoneal macrophages (Fig.
4). All cells except for monocytes
displayed a constitutively high level of tag7 mRNA.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 4.
Northern blot analysis of tag7
transcription in lymphoid and hematopoietic cells. Total RNA
was isolated from the indicated mouse cells cultured with medium alone
or LPS-stimulated. All lanes used 20 µg of total RNA.
Below, hybridization of the same membrane with
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is shown.
tag7 transcript is indicated by the arrow.
|
|
Stimulation with IL-2 or phytohemagglutinin did not lead to a
significant increase of the mRNA content in thymocytes and
macrophages in the time course studied (data not shown). In mouse
splenocytes cultured with LPS, the level of tag7
transcription dropped down within the first hours of activation (Fig.
4). After the first 5 h of LPS treatment, the level of
tag7 mRNA decreased twice; thereupon, induction took
place, but the increase of the mRNA level was relatively low. The
highest observed level of tag7 mRNA was observed after
24 h of stimulation (Fig. 4). However, Northern blot analysis of
murine B cell lymphoma cell line WEHI-231 and T cell lymphoma LBRM-33
did not reveal any detectable level of tag7 transcripts
(data not shown) and furthermore, no tag7 transcripts were
detected in the above cell lines stimulated with phorbol ester, LPS,
and calcium ionophore for 20 h (data not shown).
Tag7 Is a Secreted Protein and Secretion Can Be Activated in
Lymphoid Cells--
To study Tag7 expression at the protein level,
rabbit polyclonal antibodies raised against the E. coli Tag7
recombinant protein were used for Western blotting analysis of VMR-L
and CSML-0 cells (Fig. 5A).
The cells were separated from the cultivation medium and lysed.
Proteins from both cellular lysates and cultivation medium were
immunoprecipitated with anti-Tag7 antibodies, separated in
polyacrylamide gel, and transferred to membrane. Most of the Tag7
protein was detected in conditioned medium of VMR-L cells (Fig.
5A). A similar pattern of gene expression was observed for another Tag7-expressing cell line, CSML-0 (data not shown). The level
of tag7 transcription in CSML-0 cell line was higher than in
VMR-L cells (Fig. 2); however, the level of protein synthesis remained
low, and we were unable to detect Tag7 protein without immunoprecipitation with antibodies.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 5.
Tag7 is a secreted protein. Tumor cell
lines were analyzed on the expression of Tag7. A, total cell
lysates (107 cells) and conditioned medium
(supe.) of VMR-L cells were immunoprecipitated with
anti-Tag7 antibodies and were used for Western blotting. Equal number
of cells was applied for each lane. rTag7 is E. coli recombinant Tag7 protein. B, LPS stimulation of
splenocytes led not only to protein synthesis activation but also to
the secretion of the protein. Tag7 protein was also immunoprecipitated
before polyacrylamide gel electrophoresis from cellular lysates
(107 cells) or their conditioned medium. Sizes of molecular
mass markers are indicated on the right. C,
native Tag7 presumably exists in two major forms: monomer and trimer. A
Superdex 75 column was calibrated using molecular mass standards (upper
curve). Then, concentrated conditioned medium from mouse splenocytes
was applied on the column, fractions were collected and concentrated,
and Western analysis was performed.
|
|
In freshly isolated mouse splenocytes, tag7 mRNA was
present at a rather high level, but Tag7 protein was also detected in these cells only after immunoprecipitation with anti-Tag7 antibodies. Mouse splenocytes (Fig. 5B) contained a significant amount
of cellular Tag7 protein, and LPS stimulation increased its content 5-7-fold with a maximum at about 24 h. Although during the first hours of activation most of Tag7 protein was found in a
splenocyte-associated form, a long exposure of cells to LPS resulted
not only in increasing the overall amount of the protein but also in
its secretion. To determine the quaternary structure of the protein,
cultivation medium from LPS-activated mouse splenocytes was
concentrated and applied on Superdex 75HR column. Fractions were
collected and concentrated, and Western blot analysis with anti-Tag7
antibodies was performed (Fig. 5C). About half of the total
amount of the protein was detected in a 50-kDa fraction; the rest of
the protein remained in low molecular weight fractions. This fact
allowed us to suggest that secreted native Tag7 protein could also
exist as a multimeric complex.
Secreted Tag7 Induces Cell Death in an Apoptotic
Manner--
Recombinant E. coli Tag7 protein was isolated
as a denatured protein from inclusion bodies. All of our attempts to
refold the protein after purification on Ni-NTA column failed. During dialysis, the purified from the E. coli system material
irreversibly precipitated. To perform functional studies with Tag7
protein, we constructed cell line constitutively producing Tag7.
The VMR-0 cell line, which does not express tag7 (Fig.
6A), was stably transfected
with the constructions expressing the tag7 gene. For
transfections, both pBK-CMV and pM5Gneo eucaryotic expression vectors
were used; however, the pM5Gneo vector allowed us to obtain significantly higher level of Tag7 expression. We analyzed 15 G418-resistant clones on the level of Tag7 expression. In most of them,
the level of the exogenous tag7 transcription was relatively high, but Tag7 protein synthesis remained hardly detectable. The clone
with the highest level of Tag7 secretion (VMRSX8) (less than 10 ng/ml)
was selected for further studies of soluble Tag7 protein. For this,
L929 cells were treated with either conditioned supernatant from VMRSX8
cells or from the control mock-transfected VMR-0 cells for different
time intervals. It was found that conditioned medium from VMRSX8 cells
caused death in target L929 cells. Maximum cytotoxicity was observed at
5 h and did not increase significantly after 24 h incubation
(Fig. 6B). The results obtained demonstrated that both TNF
and Tag7 killed L929 cells in the presence of actinomycin D. Addition
of anti-Tag7 polyclonal antibodies specifically blocked cell death
caused by VMRSX8 supernatant and did not affect TNF-induced apoptosis.
At the same time, anti-TNF antibodies did not block Tag7-induced cell
death. The supernatant from VMR-0 cells did not possess any cytotoxic
activity. Human breast adenocarcinoma cell line MCF7 was also
susceptible to Tag7 killing (data not shown).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 6.
Soluble Tag7 protein is a cytolytic agent
that induces cell death in the apoptotic manner. A,
conditioned medium of 107 of mock-transfected VMR-0 and
VMRSX8 cells were immunoprecipitated with anti-Tag7 antibodies and were
used for Western blotting. B, L929 cells were cultured for
5 h in the presence of mock-transfected VMR-0- and
VMRSX8-conditioned medium or rhTNF (10 ng/ml) under the indicated
conditions. Cell death was assayed by trypan blue staining (conditioned
medium and rhTNF) or lactate dehydrogenase release (rhTNF). Data
represent cell death minus spontaneous cell death and in presence of
rabbit IgG. Error bars represent the S. D. of measurements
from five independent experiments, and the values are the average of
these measurements. C, oligonucleosomal DNA fragmentation
induced by supernatant of VMRSX8 cells. L929 cells were cultured for
5 h with conditioned medium of mock-transfected VMR-0, VMRSX8, or
rhTNF as indicated, and then fragmented DNA was recovered and resolved
by 1.8% agarose gel electrophoresis in TBE. Positions of size markers
are shown on the left.
|
|
Because the process of apoptosis is known to rapidly induce DNA
fragmentation, the ability of the secreted form of Tag7 to trigger
apoptosis was examined utilizing a DNA fragmentation assay. Conditioned
supernatant of VMRSX8 cells was added to target L929 cells. As
controls, we used mock-transfected VMR-0-conditioned medium and
recombinant TNF. After a 5-h incubation, fragmented DNA in the
cytoplasm was recovered and resolved by agarose gel electrophoresis.
Murine L929 cells were triggered to undergo apoptosis by the soluble
form of the Tag7 protein and recombinant TNF but not with supernatant
from VMR-0 cells as, evidenced from intranucleosomal DNA fragmentation
(Fig. 6C).
NF- B Accumulation Is Not Activated in Target Cells by
Tag7--
TNF has been shown to induce apoptosis and NF- B
activation, two of the most important activities signaled by TNFR-1
(22). We investigated whether Tag7 does also activate NF- B. VMR-0
cells stably transfected with tag7-expressing construct
(VMRSX8) did not show changed viability and proliferation. To
investigate the NF- B activation in sensitive to Tag7 cells, L929
cells were treated with either conditioned supernatant from cells
transfected with tag7 (VMRSX8) or recombinant human TNF in
concentration 10 ng/ml. Nuclear extracts were prepared 2 h later,
and reacted with end-labeled NF- B specific probe and subjected to
EMSA (Fig. 7). Tag7 did not induce
detectable NF- B activation in L929 cells, although cytotoxicity of
Tag7 was significantly higher than that of TNF during short-term of
exposure of the cells to these cytotoxic agents.

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 7.
Soluble Tag7 does not induce NF- B
activation in mouse L929 cells. L929 cells were treated with
rhTNF-, VMR-0-, or VMRSX8-conditioned medium and analyzed for NF- B
activation. As a control, nuclear extracts from untreated L929 cells
were used. Free DNA is not shown.
|
|
 |
DISCUSSION |
During the last decade, a number of TNF-related cytokines were
identified and cloned. Some of them are produced by tumor cells (11,
23). Using the "differential display" technique, we have isolated a
novel mouse gene with a remote homology to the TNF family of ligands.
It came out first from the genomic organization of the tag7
gene. It is similar to the mouse LT- three-exon structure and the
noncanonical TATA box with multiple transcription initiation sites. The
promoter regions of TNF, lymphotoxins, and tag7 genes show
similarity in regulatory elements, although their combination is unique
for each gene.
The tissue specificity of tag7 expression also resembles
that of mouse LT- expression with quite a few exceptions. In
situ hybridization analysis for tag7 on sections of
selected organs also demonstrated the pattern of the signal
distribution close to LT- mRNA. The total level of
tag7 mRNA in brain was very low; however, specific cell
types gave a strong hybridization signal upon in situ
hybridization. Specific cortical areas of the brain (the hippocampus
and Purkinje cells of the cerebellum) (Fig. 3, B and
C) showed a high level of tag7 mRNA content.
The same pattern of gene transcription was observed for the mouse
LT- (21) gene. Only minor differences in the patterns of
tag7 and LT- mRNA distribution were observed.
Lymphoid and hematopoietic organs contained Tag7-expressing cells,
although in the thymus, the level of tag7 transcription was
very low. On the other hand, the level of tag7 transcription in spleen was very high, and on sections, tag7 mRNA was
detected almost everywhere (data not shown), whereas LT- mRNA
was predominantly expressed in the white pulp. This implies that two
genes may still be differentially regulated and activated through
different signaling pathways. A significant level of tag7
transcription in lungs could be attributed to the large amount of
alveolar macrophages.
The presence in the regulatory region of the tag7 gene of
NF- B binding site supposed very fast response on well-known stimuli, e.g. LPS or phorbol 12-myristate 13-acetate, which could
result in increased transcription of the gene. We detected
down-regulation of tag7 transcription in lymphocytes at the
early stages of activation. A similar type of down-regulation of TNF
mRNA expression in macrophages is mediated through the regulation
of NF- B activation (24, 25). The reduction in tag7
transcription indicates that additional nuclear factors may be missing
or that silencers may be activated in such a way that transcription of
the tag7 gene is prevented. Activation of the
tag7 gene expression was relatively low in splenocytes and
tumor cell lines expressing the gene: VMR-L and CSML-0. Alteration in
the level of tag7 transcription after establishment
transplanted tumors as a cell lines points to the participation of host
factors in tag7 transcription. It was further supported by
the observation that in B and T cell lines, we were unable to detect
tag7 mRNA, although its transcription was abundant in
freshly isolated splenocytes. However, we can not rule out the
possibility that splenocytes became activated due to isolation
procedure.
A constitutive level of tag7 expression in the lymphoid and
hematopoietic tissues points to a role for this gene in immune system.
Furthermore, it is evident that the main step in regulation cascade
occurred at the posttranscriptional level. Even insignificant changes
in the mRNA production result in a change of overall amount of
protein synthesized and its secretion, although constitutive level of
Tag7 protein in isolated lymphoid cells is rather high.
We did not find any significant homology for Tag7 with any known
proteins. However, similarity in genomic organization and expression
pattern with lymphotoxin- motivated us for more detailed amino acid
sequence analysis. Low homology allowed multiple alignments, but this
analysis revealed the existence of five regions of low homology in the
extracellular domains of the Tag7 polypeptide and TNF family members
(Fig. 8). In the first two regions, the level of identity with other TNF family ligands is relatively high,
especially in residues buried in the -sheet interior (26). The rest
of the domains show less homology, but the buried residues are still
conservative. Moreover, gel filtration data support the similarity in
quaternary structure of Tag7 and TNF family ligands. Like lymphotoxins
and TNF itself, native secreted Tag7 was detected as a multimer, and
the molecular weight of the complex allows us to speculate that it
forms trimers. However, whether Tag7 forms homo- or heterotrimers
is unknown. Tag7 is rich in cysteine residues and, like LT- ,
contains 4 methionine residues (27).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 8.
An amino acid sequence comparison of Tag7 and
the TNF family of ligands. The alignment is arranged to show
maximum similarity of Tag7 and the TNF-like cytokines that are most
close to Tag7 . The similarity in the rest of the sequence is much
lower than shown here. b indicates residues buried in the
-sheet interior of ligands of the TNF family that are similar for
the proteins shown.
|
|
The tag7 gene was mapped on mouse chromosome 7. Previously,
it was observed that many of TNF-related genes are clustered in the
genome. TNF/lymphotoxins genes are linked on mouse chromosome 17 and
human chromosome 6 (28-30). The tag7 gene does not map on the same chromosome with other known TNF ligand family members. Chromosome location offers a possible in vivo role of the
tag7 gene. The cytogenetic band 7A3 has been genetically
linked with lupus-like nephritis in the MRL and New Zealand hybrid
models of systemic lupus erythrematosus (31, 32). Although systemic lupus erythrematosus is unlikely to involve mutations with severe functional alterations, gene knockout experiments may provide insight
into pathogenic process.
Tag7 released in conditioned medium possesses cytotoxicity and triggers
intranucleosomal DNA fragmentation in target cells in the same way as
many known members of the TNF family. Fragmentation of DNA is one of
the characteristics of apoptosis. We can not exclude possibility that
Tag7 acts via binding with known "death domain" receptors, but it
is unlikely that TNF receptor is involved in the apoptotic cell death
caused by Tag7. Cell lines that naturally produce Tag7 protein, such as
CSML-0 or VMR-0 (which was engineered to produce it) (33), are easily
susceptible to killing by TNF. Another piece of evidence that points to
the existence of a specific Tag7 receptor is the existence of different
pathways of signal transduction. In addition to inducing apoptosis, TNF
receptor 1, CD95 (Apo1), DR3, DR4, and DR5 can activate the
transcription factor NF- B (34-36), which controls expression of
multiple immunomodulatory genes (37). We did not detect up-regulation
of nuclear NF- B in target L929 cells in the presence of secreted
Tag7 protein. However, we can not rule out the possibility that in
another system, Tag7 would induce NF- B activation, as observed for
TRAIL (TNF-related apoptosis-inducing ligand) receptors (38).
A tumor can produce cytokine; this may have important consequences,
which may be direct (promoting or inhibiting tumor growth) or indirect
(changing such growth through interactions on the microenvironment).
The effect of a single cytokine, however, cannot be readily predicted,
because its presence induces other cytokine(s), which can significantly
affect the primary action. Recent studies with the tumor cells
transformed with tag7 demonstrated the important role of the
gene in tumor growth.2
 |
ACKNOWLEDGEMENTS |
We thank O. Borodulina and A. Ruzov for
technical assistance and I. Korobko for help in manuscript
preparation.
 |
FOOTNOTES |
*
This work was supported by International Association
for the Promotion of Cooperation with Scientists from the New
Independent States of the Former Soviet Union (INTAS) Grant
N1010-CT93-0029, Pharmaceutical European Community Organization
Grant ERB3530PL941128, the Russian Foundation for Basic Research, and
the Moscow Anticancer Program.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) X86374 (cDNA) and Y12088 (genomic DNA).
§
These authors contributed equally to this work.
¶
To whom correspondence should be addressed. Tel.:
7-095-1359970; Fax: 7-095-1354105; E-mail: slk{at}mx.ibg.rssi.ru.
1
The abbreviations used are: IL, interleukin;
TNF, tumor necrosis factor; rhTNF, recombinant human TNF; LT,
lymphotoxin; LPS, lipopolysaccharide; kb, kilobase pair; bp, base
pair.
2
S. L. Kiselev, O. S. Kustikova,
E. V. Korobko, and G. P. Georgiev, manuscript in
preparation.
 |
REFERENCES |
-
Pekarek, L. A.,
Weichselbaum, R. R.,
Beckett, M. A.,
Nachman, J.,
and Schreiber, H.
(1993)
Cancer Res.
53,
1978-1981[Abstract/Free Full Text]
-
Kruger-Krasagakes, S.,
Krasagakis, K.,
Garbe, C.,
and Diamantstein, T.
(1995)
Recent Res. Cancer Res.
139,
155-168[Medline]
[Order article via Infotrieve]
-
Van Meir, E. G.
(1995)
Glia
15,
264-288[CrossRef][Medline]
[Order article via Infotrieve]
-
Oka, M.,
Hirose, K.,
Iizuka, N.,
Aoyagi, K.,
Yamamoto, K.,
Abe, T.,
Hazama, S.,
and Suzuki, T.
(1995)
J. Interferon Cytokine Res.
15,
1005-1009[Medline]
[Order article via Infotrieve]
-
Sporn, M. B.,
and Todaro, G. J.
(1980)
N. Engl. J. Med.
303,
878-880[Medline]
[Order article via Infotrieve]
-
Colombo, M. P.,
Modesti, A.,
Parmiani, G.,
and Forni, G.
(1992)
Cancer Res.
52,
4853-4857[Free Full Text]
-
Vassalli, P.
(1992)
Annu. Rev. Immunol.
10,
411-452[CrossRef][Medline]
[Order article via Infotrieve]
-
Paul, N.,
and Ruddle, N.
(1988)
Annu. Rev. Immunol.
6,
407-438[CrossRef][Medline]
[Order article via Infotrieve]
-
de Kossodo, S.,
Grau, G. E.,
Daneva, T.,
Pointaire, P.,
Fossati, L.,
Ody, C.,
Zapf, J.,
Piguet, P. F.,
Gaillard, R. C.,
and Vassalli, P.
(1992)
J. Exp. Med.
176,
1259-1264[Abstract/Free Full Text]
-
Rubin, B. Y.,
Anderson, S. L.,
Sullivan, S. A.,
Williamson, B. D.,
Carswell, E. A.,
and Old, L. J.
(1986)
J. Exp. Med.
164,
1350-1355[Abstract/Free Full Text]
-
Spriggs, D. R.,
Imamura, K.,
Rodriguez, C.,
Sariban, E.,
and Kufe, D. W.
(1988)
J. Clin. Invest.
81,
455-460
-
Ishibashi, K.,
Ishitsuka, K.,
Chuman, Y.,
Otsuka, M.,
Kuwazuru, Y.,
Iwahashi, M.,
Utsunomiya, A.,
Hanada, S.,
Sakurami, T.,
and Arima, T.
(1991)
Blood
77,
2451-2455[Abstract/Free Full Text]
-
Senin, V. M.,
Ivanov, A. M.,
Afanasyeva, A. V.,
and Buntsevich, A. M.
(1984)
Vestn. Akad. Med. Nauk USSR
5,
85-91
-
Klaus, G. G. B.
(1988)
in
Lymphocytes. A Practical Approach (Klaus, G. G. B., ed), pp. 15-67, IRL Press, Washington, D. C.
-
Liang, P.,
and Pardee, A. B.
(1992)
Science
257,
967-971[Abstract/Free Full Text]
-
Sambrook, J.,
Fritsch, E.,
and Maniatis, T.
(1990)
Molecular Cloning: A Laboratory Manual, 3rd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Ausubel, F. M., Brent, R., Kingston, R. E., More, D. D.,
Seidman, J. G., Smith, J. A., and Struhl, K. (1992) in
Short Protocols in Molecular Biology (Ausubel, F. M., Smith, J. A., and Struhl, K., eds) 2nd Ed., pp. 14.2-14.29,
Harvard Medical School, Greene Publishing Associates, New York
-
Tian, Q.,
Streuli, M.,
Saito, H.,
Schlossman, S. F.,
and Anderson, P.
(1991)
Cell
67,
629-639[CrossRef][Medline]
[Order article via Infotrieve]
-
Dignam, J. D.,
Lebovitz, R. M.,
and Roeder, R. G.
(1983)
Nucleic Acids Res.
11,
1475-1489[Abstract/Free Full Text]
-
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1987)
Current Protocols in Molecular Biology, p. 2.12 and 12.31-12.35, Green Publishing Associates, New York
-
Pokholok, D. K.,
Maroulakou, I. G.,
Kuprash, D. V.,
Alimzhanov, M. B.,
Kozlov, S. V.,
Novobratseva, T. I.,
Turetskaya, R. L.,
Green, J. E.,
and Nedospasov, S. A.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
674-678[Abstract/Free Full Text]
-
Hsu, H.,
Xiong, J.,
and Goeddel, D. V.
(1995)
Cell
81,
495-504[CrossRef][Medline]
[Order article via Infotrieve]
-
Armitage, G.,
Sato, T. A.,
MacDaf, B. M.,
Clifford, K. N.,
Alpet, A. R.,
Smith, C. A.,
and Fanslow, W. C.
(1992)
Eur. J. Immunol.
22,
2071-2076[Medline]
[Order article via Infotrieve]
-
Takasuka, N.,
Tokunaga, T.,
and Akagawa, K. S.
(1991)
J. Immunol.
146,
3824-3830[Abstract]
-
Takasuka, N.,
Matsuura, K.,
Yamamoto, S.,
and Akagawa, K. S.
(1995)
J. Immunol.
154,
4803-4812[Abstract]
-
Smith, C.,
Farrah, T.,
and Goodvin, R. G.
(1994)
Cell
76,
959-962[CrossRef][Medline]
[Order article via Infotrieve]
-
Aggarwal, B. B.,
Henzel, W. J.,
Moffat, B.,
Kohr, W. J.,
and Harkins, R. N.
(1985)
J. Biol. Chem.
260,
2334-2339[Abstract/Free Full Text]
-
Spies, T.,
Morton, C. C.,
Nedospasov, S. A.,
Fiers, W.,
Pious, D.,
and Strominger, J. L.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
8699-8702[Abstract/Free Full Text]
-
Nedospasov, S. A.,
Hirt, B.,
Shakhov, A. N.,
Dobrynin, V. N.,
Kawashima, E.,
Accolla, R. S.,
and Jongeneel, C. V.
(1986)
Nucleic Acids Res.
14,
7713-7725[Abstract/Free Full Text]
-
Gardner, S. M.,
Mock, B. A.,
Hilgers, J.,
Huppi, K. E.,
and Roeder, W. D.
(1987)
J. Immunol.
139,
476-483[Abstract]
-
Kono, D. H.,
Burlingame, R. W.,
Owens, D. G.,
Kuramochi, A.,
Balderas, R. S.,
Balomenos, D.,
and Theofilopoulos, A. N.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10168-10172[Abstract/Free Full Text]
-
Morel, L.,
Rudofsky, U. H.,
Longmate, J. A.,
Schiffenbauer, J.,
and Wakeland, E. K.
(1994)
Immunity
1,
219-229[CrossRef][Medline]
[Order article via Infotrieve]
-
Korobko, E. V., Saschenko, L. P., Prockhorchouk, E. B.,
Korobko, I. V., Gnuchev, N. V., and Kiselev, S. L. Cell Death Differ., in press
-
Chinnaiyan, A. M.,
O'Rourke, K.,
Yu, G. L.,
Lyons, R. H.,
Garg, M.,
Duan, D. R.,
Xing, L.,
Gentz, R.,
Ni, J.,
and Dixit, V. M.
(1996)
Science
274,
990-992[Abstract/Free Full Text]
-
Kitson, J.,
Raven, T.,
Jiang, Y. P.,
Goeddel, D. V.,
Giles, K. M.,
Pun, K. T.,
Grinham, C. J.,
Brown, R.,
and Farrow, S. N.
(1996)
Nature
384,
372-375[CrossRef][Medline]
[Order article via Infotrieve]
-
Marsters, S. A.,
Sheridan, J. P.,
Donahue, C. J.,
Pitti, R. M.,
Gray, C. L.,
Goddard, A. D.,
Bauer, K. D.,
and Ashkenazi, A.
(1996)
Curr. Biol.
6,
1669-1676[CrossRef][Medline]
[Order article via Infotrieve]
-
Baldwin, A. S.
(1996)
Annu. Rev. Immunol.
14,
649-683[CrossRef][Medline]
[Order article via Infotrieve]
-
Pan, G.,
O'Rourke, K.,
Chinnaiyan, A. M.,
Gentz, R.,
Ebner, R.,
Ni, J.,
and Dixit, V. M.
(1997)
Science
276,
111-113[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. H. Cho, I. P. Fraser, K. Fukase, S. Kusumoto, Y. Fujimoto, G. L. Stahl, and R. A. B. Ezekowitz
Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity
Blood,
October 1, 2005;
106(7):
2551 - 2558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. McDonald, N. Inohara, and G. Nunez
Peptidoglycan Signaling in Innate Immunity and Inflammatory Disease
J. Biol. Chem.,
May 27, 2005;
280(21):
20177 - 20180.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. Moiseyenko, A. O. Danilov, I. A. Baldueva, A. B. Danilova, N. V. Tyukavina, S. S. Larin, S. L. Kiselev, R. V. Orlova, V. V. Anisimov, A. I. Semenova, et al.
Phase I/II trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors
Ann. Onc.,
January 1, 2005;
16(1):
162 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Kappeler, C. Heuberger, Z. Farah, and Z. Puhan
Expression of the Peptidoglycan Recognition Protein, PGRP, in the Lactating Mammary Gland
J Dairy Sci,
August 1, 2004;
87(8):
2660 - 2668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. P. Sashchenko, E. A. Dukhanina, D. V. Yashin, Y. V. Shatalov, E. A. Romanova, E. V. Korobko, A. V. Demin, T. I. Lukyanova, O. D. Kabanova, S. V. Khaidukov, et al.
Peptidoglycan Recognition Protein Tag7 Forms a Cytotoxic Complex with Heat Shock Protein 70 in Solution and in Lymphocytes
J. Biol. Chem.,
January 16, 2004;
279(3):
2117 - 2124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Saito, T. Tanaka, H. Kanda, Y. Ebisuno, D. Izawa, S. Kawamoto, K. Okubo, and M. Miyasaka
Gene Expression Profiling of Mucosal Addressin Cell Adhesion Molecule-1+ High Endothelial Venule Cells (HEV) and Identification of a Leucine-Rich HEV Glycoprotein as a HEV Marker
J. Immunol.,
February 1, 2002;
168(3):
1050 - 1059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Izawa, T. Tanaka, K. Saito, H. Ogihara, T. Usui, S. Kawamoto, K. Matsubara, K. Okubo, and M. Miyasaka
Expression profile of active genes in mouse lymph node high endothelial cells
Int. Immunol.,
December 1, 1999;
11(12):
1989 - 1998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ochiai and M. Ashida
A Pattern Recognition Protein for Peptidoglycan. CLONING THE cDNA AND THE GENE OF THE SILKWORM, BOMBYX MORI
J. Biol. Chem.,
April 23, 1999;
274(17):
11854 - 11858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Liu, E. Gelius, G. Liu, H. Steiner, and R. Dziarski
Mammalian Peptidoglycan Recognition Protein Binds Peptidoglycan with High Affinity, Is Expressed in Neutrophils, and Inhibits Bacterial Growth
J. Biol. Chem.,
August 4, 2000;
275(32):
24490 - 24499.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|